Data Quality and Technology in Clinical Trials 2016 covers topics such as:
- Become a data company: Work with pharma’s leaders to design the analytics-driven organization of the future
- Maximize data quality: Enhance your trial rate of success with the perfect protocol design
- Focus on what matters: Achieve a structured risk identification, analysis, and measurement and successfully transition to Risk Based Monitoring
- Harness the right analytics: Translate and adopt the hidden message behind your data
- Why Attend?
- Align your objectives with your sites: Collaborate with key stakeholders and optimize the information exchange
- An Agenda that addresses what really matters: The unique compelling document is an objective reflection of months of research with +100 top pharma executives
- First clinical meeting chaired by the FDA: Hear directly from regulators on various topics such as new types patient data and when does the generated insight cross regulatory lines
- Audience will make the impact in the industry: +150 pharma decision makers attending the meeting will bring back and implement exclusive insight to their organization
- Each topic will be addressed by the industry’s thought leader: Handpicked 20+ industry leading speakers including C-Suite, VP and Director level experts to share their experiences so you can design better trials using the latest technologies, analytics and techniques
Data Quality and Technology in Clinical Trials 2016 brings together senior attendees with responsibilities in:
- Clinical Innovation
- Global Clinical Trial Operations
- Clinical Projects & Quantitative Sciences
- Information Strategy and Analytics
- Study Data Management
- Early Development Operation
- R&D Information Strategy and Analytics
- Information Strategy and Analytics
- Data Acquisition Services
- Clinical Development Information & Optimization
- Data Acquisition Services
- Global Data Sciences and Analytics
- Global Regulatory Affairs
